Comparing reflux risk across GLP-1 medications If reflux becomes unmanageable on semaglutide, understanding how it compares to alternatives helps inform discussions with your prescriber about switching options
These medications were originally developed to treat type 2 diabetes because of their ability to improve blood sugar control
What is the difference between fillers
Key Takeaways GLP-1 medications slow digestion, which can lead to nausea, bloating, reflux, gas, and changes in bowel habits
Mounjaro, a similar diabetes drug produced by Eli Lilly with the active ingredient tirzepatide, launched in mid-2022
[1] [2] This distinction is clinically significant because dosing errors can lead to serious consequences